Redeye provides an initial comment on Relais issuing cEUR50m in hybrid bonds to replace its recent b...
Atria announced today its TOGETHER 2030 strategy for 2025-30 with refined financial targets.
We initiate coverage of YIT with a REDUCE-rating and TP of EUR 3.
Första halvåret visade högre intäkter än föregående år, och tidiga beställningar inför tredje kvarta...
Nettoomsättningen steg 26 % till 18 mkr, drivet av egenutvecklade produkter (+44 % till 7,4 mkr) med...
Redeye comments on Verve's announced acquisition. The company is acquiring Acardo Group for EUR24.
Redeye leaves a comment following OncoZenge’s announcement of a collaboration with UCLA, marking an ...
Redeye is not surprised by the high subscription rate, considering the share has traded above the st...
Xplora is one of the leading players within smartwatches for kids and phones for seniors (65+), with...
Redeye is pleased with TO13’s preliminary subscription rate of 91%.
Grangex nya DFS för Sydvaranger ökar visibiliteten och pekar på ytterligare värden.
EU-kommittén har röstat för ett godkännande av XP Chemistries kapsaicin som fodertillsats för alla d...
Redeye initiates coverage of Fractal Gaming Group, a Swedish premium gaming hardware brand best know...
Redeye comments on Cinclus’ announcement that the first patient has been screened in its pivotal Pha...
Redeye briefly comments on Guard announcing that the data collection for the phase IIb study POINTER...
Yesterday, Scibase announced that Ribbskottet AB and Life Science Investment Fund (LSIF), have each ...
Redeye comments on Acarix following recent news relating to the ownership structure, where, among ot...
Redeye updates its view on Thunderful. Atari’s majority acquisition (80%) of Thunderful offers clear...
Biovica records SEK 2.6m in total net sales (51% above Q1 last year), and clinical sales increased b...
Redeye makes an initial comment about the new targets and cost savings.
